Tylenol and Autism (Evidence, Scientific Blunders, and Medicine Gone Wrong)
List Price:
$32.99
| Expected release date is Jun 23rd 2026 |
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
William Parker
Format:
Hardcover
Pages:
312
Publisher:
Skyhorse Publishing (June 23, 2026)
Imprint:
Childrens Health Defense Books
Release Date:
June 23, 2026
Language:
English
ISBN-13:
9781648212468
ISBN-10:
1648212468
Weight:
17.87oz
Dimensions:
6" x 9"
File:
Eloquence-SimonSchuster_04172026_P9969852_onix30-20260417.xml
List Price:
$32.99
Pub Discount:
65
Case Pack:
24
As low as:
$25.40
Publisher Identifier:
P-SS
Discount Code:
A
Folder:
Eloquence
Overview
Tylenol and Autism: Evidence, Scientific Blunders, and Medicine Gone Wrong by William Parker, PhD, is a provocative, evidence-focused investigation into the disputed “Tylenol autism link”—the hypothesis that acetaminophen (Tylenol/paracetamol/APAP) exposure can trigger autism spectrum disorder (ASD) in biologically susceptible babies and young children.
Rather than relying on a single study, Parker organizes roughly 30 distinct lines of evidence across pharmacology and metabolism, human associations involving time/place/behavior, laboratory animal neurodevelopmental toxicity, and additional observations—then weighs that total body of evidence against alternative explanations and common objections.
The book digs into proposed mechanisms (including early-life limits in detoxification pathways, oxidative stress–linked susceptibility, and gut–brain effects) and emphasizes “timing of risk” from pregnancy through labor/delivery and early childhood.
Beyond the science, it examines the logic of the controversy—how statistical mistakes (such as misclassifying interacting variables as confounders), peer-review failures, and conflicts of interest can shape medical consensus.
In Tylenol and Autism, Dr. Parker confronts, with intelligence, honesty, and bravery, what is an undeniably culturally and politically explosive issue intensified by the 2025 White House spotlight on acetaminophen and autism.
Rather than relying on a single study, Parker organizes roughly 30 distinct lines of evidence across pharmacology and metabolism, human associations involving time/place/behavior, laboratory animal neurodevelopmental toxicity, and additional observations—then weighs that total body of evidence against alternative explanations and common objections.
The book digs into proposed mechanisms (including early-life limits in detoxification pathways, oxidative stress–linked susceptibility, and gut–brain effects) and emphasizes “timing of risk” from pregnancy through labor/delivery and early childhood.
Beyond the science, it examines the logic of the controversy—how statistical mistakes (such as misclassifying interacting variables as confounders), peer-review failures, and conflicts of interest can shape medical consensus.
In Tylenol and Autism, Dr. Parker confronts, with intelligence, honesty, and bravery, what is an undeniably culturally and politically explosive issue intensified by the 2025 White House spotlight on acetaminophen and autism.
